'Close-to-ideal' tumor boron targeting for boron neutron capture therapy is possible with 'less-than-ideal' boron carriers approved for use in humans

Ther Deliv. 2015 Mar;6(3):269-72. doi: 10.4155/tde.14.108.
No abstract available

Keywords: BPA; GB-10; boron compounds approved for use in humans; boron neutron capture therapy (BNCT); optimization of boron tumor targeting.

Publication types

  • Editorial

MeSH terms

  • Boron Neutron Capture Therapy*
  • Humans
  • Neoplasms / radiotherapy*